BPG is committed to discovery and dissemination of knowledge
Featured Articles
6/15/2023 8:57:40 AM | Browse: 406 | Download: 1112
Publication Name World Journal of Diabetes
Manuscript ID 84159
Country Malaysia
Received
2023-02-28 10:14
Peer-Review Started
2023-02-28 10:17
First Decision by Editorial Office Director
2023-03-14 08:09
Return for Revision
2023-03-14 08:09
Revised
2023-03-25 16:52
Publication Fee Transferred
Second Decision by Editor
2023-04-23 03:24
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2023-04-24 03:24
Articles in Press
2023-04-24 03:24
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-05-09 03:26
Publish the Manuscript Online
2023-06-15 08:52
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Review
Article Title Adiponectin as a therapeutic target for diabetic foot ulcer
Manuscript Source Invited Manuscript
All Author List Mona Mohamed Ibrahim Abdalla, Jaiprakash Mohanraj and Sushela Devi Somanath
Funding Agency and Grant Number
Corresponding Author Mona Mohamed Ibrahim Abdalla, MSc, PhD, Senior Lecturer, Department of Human Biology, School of Medicine, International Medical University, No. 126 Jln Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Malaysia. monamohamed@imu.edu.my
Key Words Diabetic foot ulcer; Adiponectin; Anti-inflammatory; Adipose tissue; Antioxidants; Wound healing
Core Tip The global burden of diabetic foot ulcers (DFUs) is significant, both in terms of human suffering and healthcare costs. Therefore, effective strategies to prevent and treat DFUs are urgently needed. Adiponectin, a hormone produced by adipose tissue, shows promise as a therapeutic option for DFUs due to its anti-inflammatory, antioxidant, and pro-angiogenic effects. While adiponectin has potential therapeutic applications, further research is necessary to establish its safety and efficacy in clinical settings. This review aims to summarize current research on adiponectin’s potential role in treating DFUs and identify areas requiring further investigation.
Publish Date 2023-06-15 08:52
Citation Abdalla MMI, Mohanraj J, Somanath SD. Adiponectin as a therapeutic target for diabetic foot ulcer. World J Diabetes 2023; 14(6): 758-782
URL https://www.wjgnet.com/1948-9358/full/v14/i6/758.htm
DOI https://dx.doi.org/10.4239/wjd.v14.i6.758
Full Article (PDF) WJD-14-758-with-cover.pdf
Full Article (Word) WJD-14-758.docx